Actively Recruiting
Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
Led by Institut Curie · Updated on 2026-04-14
2050
Participants Needed
2
Research Sites
471 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Multi-cohort exploratory prospective study. Participation in the ALCINA 4 study does not change the standard management of the patient, including the treatments administered. A sampling schedule will be set up for each cohort. Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples (or more) taken per patient for up to 18, 24 or 36 months. If a specific tumor sample is required, it will be collected only once during the study.
CONDITIONS
Official Title
Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient treated for cancer at one of the participating centers
- 18 years old or higher
- Signed informed consent form
- Patient not deprived of their liberty or under guardianship (including temporary guardianship)
- Patient covered by social security scheme
- Patient with no compliance issue (related to geographical, social or psychological reasons) for study follow up
- Other additional criteria will be defined (defining tumor type and clinical setting), by cohort
- Tumor considered as accessible by biopsy (if biopsy is to be taken)
- Normal blood coagulation tests (if applicable, and in case of a non-superficial tumor lesion)
- No anticoagulant or antiaggregant treatment for the biopsy
You will not qualify if you...
- Pregnant and/or breast-feeding women depending on cohort
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Institut Curie
Paris, France, 75005
Actively Recruiting
2
Institut Curie
Saint-Cloud, France, 92210
Actively Recruiting
Research Team
M
Marie-Emmanuelle LEGRIER
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
12
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here